Application of Novel Solid Lipid Nanoparticle (SLN)-Gene Vector Formulations Based on a Dimeric HIV-1 TAT-Peptide in Vitro and in Vivo

Author: Rudolph Carsten   Schillinger Ulrike   Ortiz Aurora   Tabatt Kerstin   Plank Christian   Müller Rainer H.   Rosenecker Joseph  

Publisher: Springer Publishing Company

ISSN: 0724-8741

Source: Pharmaceutical Research, Vol.21, Iss.9, 2004-09, pp. : 1662-1669

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content